Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules. (Record no. 16532654)

MARC details
000 -LEADER
fixed length control field 01454 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515040759.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200609s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1742-5247
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1517/17425247.3.5.663
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ye, Ming
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060929
245 00 - TITLE STATEMENT
Title Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert opinion on drug delivery
Date of publication, distribution, etc. Sep 2006
300 ## - PHYSICAL DESCRIPTION
Extent 663-75 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Delayed-Action Preparations
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Delivery Systems
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactic Acid
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oligopeptides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peptides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polyethylene Glycols
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polyglycolic Acid
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polylactic Acid-Polyglycolic Acid Copolymer
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polymers
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proteins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Solubility
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bhat, Gajanan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Johnston, Kevin A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tan, Heow
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garnick, Marc
773 0# - HOST ITEM ENTRY
Title Expert opinion on drug delivery
Related parts vol. 3
-- no. 5
-- p. 663-75
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1517/17425247.3.5.663">https://doi.org/10.1517/17425247.3.5.663</a>
Public note Available from publisher's website

No items available.